Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)

Although nivolumab is known to cause immune-related interstitial lung diseases (ILD), the detailed characteristics of ILD are still not fully understood. A 68-year-old man was treated with nivolumab because of unresectable sinonasal melanoma, he achieved a complete response soon after the initiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiwata, Tsukasa, Ebata, Takahiro, Iwasawa, Shunichiro, Matsushima, Jun, Ota, Satoshi, Nakatani, Yukio, Tsushima, Kenji, Tada, Yuji, Tatsumi, Koichiro, Takiguchi, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635305/
https://www.ncbi.nlm.nih.gov/pubmed/28794361
http://dx.doi.org/10.2169/internalmedicine.8271-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635305/
https://www.ncbi.nlm.nih.gov/pubmed/28794361
http://dx.doi.org/10.2169/internalmedicine.8271-16

Ejemplares similares